HY-P74742-10ug
|
MedChemexpress LLC
|
MST1/STK4, Human (sf9, His)
|
|
|
|
HY-P74742-50ug
|
MedChemexpress LLC
|
MST1/STK4, Human (sf9, His)
|
|
|
|
HY-N3239-5mg
|
MedChemexpress LLC
|
Mu lberrofuran G [CAS 87085-00-5]
|
|
COVID-19-anti-virus
|
|
HY-100669-10mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-100mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-2mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-25mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-5mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-50mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-1mL
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-113056A-10mg
|
MedChemexpress LLC
|
N1-Acetylspermidine (hydrochloride) [CAS 34450-16-3]
|
|
Cancer-programmed cell death
|
|
HY-113056A-100mg
|
MedChemexpress LLC
|
N1-Acetylspermidine (hydrochloride) [CAS 34450-16-3]
|
|
Cancer-programmed cell death
|
|
HY-113056A-25mg
|
MedChemexpress LLC
|
N1-Acetylspermidine (hydrochloride) [CAS 34450-16-3]
|
|
Cancer-programmed cell death
|
|
HY-113056A-5mg
|
MedChemexpress LLC
|
N1-Acetylspermidine (hydrochloride) [CAS 34450-16-3]
|
|
Cancer-programmed cell death
|
|
HY-113056A-50mg
|
MedChemexpress LLC
|
N1-Acetylspermidine (hydrochloride) [CAS 34450-16-3]
|
|
Cancer-programmed cell death
|
|
HY-113056A-1mL
|
MedChemexpress LLC
|
N1-Acetylspermidine (hydrochloride) [CAS 34450-16-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-21286-100mg
|
MedChemexpress LLC
|
N2-Isobutyryl-2'-O-methylguanosine [CAS 63264-29-9]
|
|
Cancer-programmed cell death
|
|
HY-21286-1mL
|
MedChemexpress LLC
|
N2-Isobutyryl-2'-O-methylguanosine [CAS 63264-29-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-W011725-10mg
|
MedChemexpress LLC
|
N-6-Methyl-2-deoxyadenosine [CAS 2002-35-9]
|
|
Cancer-programmed cell death
|
|
HY-W011725-25mg
|
MedChemexpress LLC
|
N-6-Methyl-2-deoxyadenosine [CAS 2002-35-9]
|
|
Cancer-programmed cell death
|
|
HY-W011725-5mg
|
MedChemexpress LLC
|
N-6-Methyl-2-deoxyadenosine [CAS 2002-35-9]
|
|
Cancer-programmed cell death
|
|
HY-W011725-50mg
|
MedChemexpress LLC
|
N-6-Methyl-2-deoxyadenosine [CAS 2002-35-9]
|
|
Cancer-programmed cell death
|
|
HY-13700-10mg
|
MedChemexpress LLC
|
Nedaplatin [CAS 95734-82-0]
|
|
Cancer-programmed cell death
|
|
HY-13700-100mg
|
MedChemexpress LLC
|
Nedaplatin [CAS 95734-82-0]
|
|
Cancer-programmed cell death
|
|
HY-13700-25mg
|
MedChemexpress LLC
|
Nedaplatin [CAS 95734-82-0]
|
|
Cancer-programmed cell death
|
|